SCHEMBL924503

SCHEMBL924503

Cc1nc(NC(=O)COC(=O)C(F)(F)F)sc1-c1ccc(Cl)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 8/20 0.48
CYP3A4 P08684 4/20 0.48
PIK3C2A O00443 2/20 0.48
PIK3C2B O00750 2/20 0.48
STK17A Q9UEE5 2/20 0.48
RPS6KA4 O75676 1/20 0.48
PIK3CD O00329 8/20 0.48
DYRK3 O43781 1/20 0.48
MAP4K4 O95819 1/20 0.48
CDK9 P50750 1/20 0.48
MAP4K2 Q12851 1/20 0.48
PIK3CG P48736 6/20 0.42
PIK3CB P42338 6/20 0.42
PIK3CA P42336 5/20 0.42
PIK3C3 Q8NEB9 1/20 0.41
CYP2D6 P10635 1/20 0.40
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL924841 0.89 PI4KB (0.49) PI4KBCYP3A4PIK3C2APIK3C2BSTK17A
SCHEMBL924341 0.87 PI4KB (0.48) PI4KBCYP3A4PIK3C2APIK3C2BSTK17A
Trifluoroacetic Acid SCHEMBL924501 0.80 PIK3CG (0.55) PI4KBCYP3A4PIK3C2APIK3C2BSTK17A
SCHEMBL924743 0.80 PIK3CB (0.68) PI4KBPIK3C2APIK3C2BPIK3CDPIK3CG
SCHEMBL925027 0.78 PIK3CG (0.64) PI4KBPIK3C2APIK3C2BPIK3CDPIK3CG
SCHEMBL926038 0.78 PIK3CD (0.75) PIK3CDPIK3CGPIK3CBPIK3CAPIK3C3
SCHEMBL924529 0.77 PIK3CG (0.45) PI4KBPIK3CDPIK3CGPIK3CBPIK3CA
SCHEMBL925661 0.77 PIK3CD (0.65) PI4KBPIK3C2APIK3C2BPIK3CDPIK3CG
SCHEMBL925874 0.77 PIK3CD (0.61) PIK3CDPIK3CGPIK3CBPIK3CAPIK3C3
SCHEMBL924504 0.77 PIK3CB (0.54) PI4KBPIK3C2APIK3C2BPIK3CDPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868188-B2 5-heteroaryl thiazoles and their use as PI3K inhibitors ASTRAZENECA AB (SE) 2011-01-11 US disclosed
EP-1841763-B1 5-HETEROARYL THIAZOLES AND THEIR USE AS PI3K INHIBITORS ASTRAZENECA AB (SE) 2010-06-30 EP disclosed
US-20080132502-A1 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors ASTRAZENECA AB (SE) 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132502-A1 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors MTOR, PIK3R5, PIK3CA PI4KB 29/4885CYP3A4 703/4885PIK3C2A 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.